2型糖尿病口服降糖药的应用-备案-培训课件.pptVIP

* 先了解下在未经药物治疗的T2DM中联合方案与单药的比较－－3705研究，这个是研究的设计方案 共433例患者，来自中国17个sites. 入组标准：此类患者特点： 以胰岛素分泌不足为主要特点 血糖异常以餐后血糖升高为主 胰岛β细胞功能较之后为好，是促泌剂使用的最佳人群 A subject must be withdrawn if the following applies: Pregnancy or intention of being pregnant Recurrent and unacceptable hypoglycaemia by the discretion of the Investigator Can’t tolerate the protocol-specified minimal dose which is repaglinide 1mg plus metformin 500mg TID for the combination therapy and repaglinide 1mg TID for the monotherapy, due to severe GI side effects or clinical reasons. Starting a medication which, in the opinion of the investigator